Anesthesiology Case Reports

Cardiology Case Reports

Dentistry Case Reports

Diabetology Case Reports

Gastroenterology Case Reports

Otolaryngology Case Reports

Rapidly developing colitis induced by combination therapy of lenvatinib and anti-PD-1 antibody


Jinyuan Ma

Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China

Correspondence to Author:  Jinyuan Ma


lthough diarrhea caused by immune checkpoint inhibitors (ICIs) or tyrosine kinase inhibitor (TKI) are common, server colitis caused by tyrosine kinase inhibitor (TKI) combined with anti-PD-1 has not been paid attention to. The combination of lenvatinib and anti-PD-1 antibody has been applied for an effort for HCC treatment. We reported two cases of initially lenvatinib induced mild diarrhea while fast developed into rather severe colitis after the first dose of anti-PD-1. We speculated that lenvatinib may be a trigger of anti-PD-1 related colitis through mediating the degradation of PD-L1 in colon tissue to make disturbance of immunity homeostasis and increasing the percentage of activated CD8+ T cells infiltration. Prevention and treatment of these related adverse effect were put forward.


Jinyuan Ma. Rapidly developing colitis induced by combination therapy of lenvatinib and anti-PD-1 antibody. Clinical Imaging and Case Reports 2022.

Journal Info

  • Journal Name: Clinical Imaging and Case Reports
  • Impact Factor: 2.709**
  • ISSN: 2770-9205
  • DOI: 10.52338/cicaserep
  • Short Name: CICASEREP
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days


  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal


  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility